Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
Isabella Russo, Giulietta Di Benedetto, Alice Kaganovich, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 146
Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration
Mahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 1, pp. 4101-4123
Closed Access | Times Cited: 59
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease
Cristina Ciampelli, Grazia Galleri, Manuela Galioto, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2093-2093
Open Access | Times Cited: 1
LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s
Rebecca L. Wallings, Mary K. Herrick, Malú G. Tansey
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 67
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
Isabella Russo, Alice Kaganovich, Jinhui Ding, et al.
Neurobiology of Disease (2019) Vol. 129, pp. 67-78
Open Access | Times Cited: 64
Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
Diego Cabezudo, Veerle Baekelandt, Evy Lobbestael
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 62
LRRK2 Phosphorylation, More Than an Epiphenomenon
Antoine Marchand, Matthieu Drouyer, Alessia Sarchione, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 53
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues
Lucia Iannotta, Alice Biosa, Jillian H. Kluss, et al.
Cells (2020) Vol. 9, Iss. 11, pp. 2344-2344
Open Access | Times Cited: 45
Non-Motor Symptoms of Parkinson’s Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction
Ayan Hussein, Christopher A. Guevara, Pamela Del Valle, et al.
The Neuroscientist (2021) Vol. 29, Iss. 1, pp. 97-116
Open Access | Times Cited: 41
The Emerging Role of Phosphodiesterases in Movement Disorders
Roberto Erro, Niccolò E. Mencacci, Kailash P. Bhatia
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2225-2243
Open Access | Times Cited: 38
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
Novel insight into the role of A-kinase anchoring proteins (AKAPs) in ischemic stroke and therapeutic potentials
Ziyu He, Letian Xie, Jiyong Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116715-116715
Open Access | Times Cited: 6
LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights
Patrick D. Skelton, Valerie Tokars, Loukia Parisiadou
Cells (2022) Vol. 11, Iss. 1, pp. 169-169
Open Access | Times Cited: 22
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2713-2741
Closed Access | Times Cited: 12
LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer’s and Parkinson’s Disease-Related Neuroinflammation
Veronica Mutti, Giulia Carini, Alice Filippini, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1799-1799
Open Access | Times Cited: 12
Therapeutic targeting of autosomal Parkinson’s disease by modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) protein
Zeeshan Hyderi, M Shirin Farhana, T.P. Singh, et al.
Brain Research (2025), pp. 149674-149674
Closed Access
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils
Alice Filippini, Giulia Carini, Alessandro Barbon, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
Ben Rombaut, Sofie Kessels, Melissa Schepers, et al.
Theranostics (2020) Vol. 11, Iss. 5, pp. 2080-2097
Open Access | Times Cited: 25
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease
Inga Peter, Warren Strober
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 279-296
Open Access | Times Cited: 9
Microglia: roles and genetic risk in Parkinson’s disease
A. Trainor, Debra S. MacDonald, Jay Penney
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Molecular Pathways Involved in LRRK2-Linked Parkinson’s Disease: A Systematic Review
Ailyn Irvita Ravinther, Hemaniswarri Dewi Dewadas, Shi Ruo Tong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11744-11744
Open Access | Times Cited: 14
LRRK2 signaling in neurodegeneration: two decades of progress
Lucia Iannotta, Elisa Greggio
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 859-872
Closed Access | Times Cited: 18
Parkinson’s-linked LRRK2-G2019S derails AMPAR trafficking, mobility, and composition in striatum with cell-type and subunit specificity
Swati Gupta, Alexander Tielemans, Christopher A. Guevara, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 28
Open Access | Times Cited: 2
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils
Alice Filippini, Valentina Salvi, Vincenzo Dattilo, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 307-307
Open Access | Times Cited: 6
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models
Nam Hoai Nguyen, Grazia Galleri, A.L. Rassu, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1555-1555
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top